Cargando…

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy

PURPOSE: Radiochemotherapy (RCT) is an effective standard therapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Nonetheless, toxicity is common, with patients often requiring dose modifications. METHODS: To investigate associations of RCT toxicities according to CTCAE versio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mollnar, S., Pondorfer, P., Kasparek, A.-K., Reinisch, S., Moik, F., Stotz, M., Halm, M., Szkandera, J., Terbuch, A., Eisner, F., Gerger, A., Kapp, K. S., Partl, R., Vasicek, S., Weiland, T., Pichler, M., Stöger, H., Thurnher, D., Posch, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936960/ https://www.ncbi.nlm.nih.gov/pubmed/32671728 http://dx.doi.org/10.1007/s12094-020-02447-y

Ejemplares similares

Long-term cardiovascular complications in stage I seminoma patients
por: Terbuch, A., et al.
Publicado: (2017)

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018)

Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy
por: Klöckl, Marie-Christin, et al.
Publicado: (2020)

Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
por: Moik, Florian, et al.
Publicado: (2019)

Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study
por: Posch, Florian, et al.
Publicado: (2017)

Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'
por: Szkandera, J, et al.
Publicado: (2013)

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
por: Terbuch, Angelika, et al.
Publicado: (2018)

Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients
por: Stelzl, Adrian, et al.
Publicado: (2020)

Head and neck cancer in Styria: An epidemiologic and clinical audit
por: Vasicek, Sarah M., et al.
Publicado: (2020)

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
por: Stotz, M, et al.
Publicado: (2014)

Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection
por: Stotz, Michael, et al.
Publicado: (2016)

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
por: Stotz, M, et al.
Publicado: (2013)

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study
por: Riedl, Jakob M., et al.
Publicado: (2020)

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer
por: Stotz, M, et al.
Publicado: (2013)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

Reply: Comment on ‘Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'
por: Szkandera, J, et al.
Publicado: (2013)

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer: A retrospective analysis
por: Asamer, Eva, et al.
Publicado: (2018)

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients
por: Klocker, Eva Valentina, et al.
Publicado: (2020)

Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
por: Szkandera, Joanna, et al.
Publicado: (2014)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
por: Szkandera, Joanna, et al.
Publicado: (2013)

Hedgehog Signaling Pathway in Ovarian Cancer
por: Szkandera, Joanna, et al.
Publicado: (2013)

Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
por: Szkandera, J, et al.
Publicado: (2014)

Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma
por: Kumpitsch, Christina, et al.
Publicado: (2020)

Sex‐specific differences in patients with nonmelanoma skin cancer of the pinna
por: Moser, Ulrich, et al.
Publicado: (2020)

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
por: Bezan, Angelika, et al.
Publicado: (2017)

Evaluation of Uric Acid as a Prognostic Blood-Based Marker in a Large Cohort of Pancreatic Cancer Patients
por: Stotz, Michael, et al.
Publicado: (2014)

Radiochemotherapy
Publicado: (1998)

LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy
por: Szkandera, J, et al.
Publicado: (2015)

A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria
por: Lill, Claudia, et al.
Publicado: (2017)

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study
por: Barth, Dominik A., et al.
Publicado: (2022)

The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer
por: Stotz, Michael, et al.
Publicado: (2020)

The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy
por: Partl, Richard, et al.
Publicado: (2020)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
por: Barth, Dominik Andreas, et al.
Publicado: (2020)

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
por: Krenn-Pilko, S, et al.
Publicado: (2014)

Combined Radiochemotherapy: Metalloproteinases Revisited
por: Waller, Verena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gg27d14sj4kmg58bu9i7gh9ihf